- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The role of RICTOR amplification in targeted therapy and drug resistance ; volume:26 ; number:1 ; day:10 ; month:2 ; year:2020 ; pages:1-11 ; date:12.2020
Molecular medicine ; 26, Heft 1 (10.2.2020), 1-11, 12.2020
- Creator
-
Zhao, Deze
Jiang, Man
Zhang, Xiaochun
Hou, Helei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-020-0146-6
- URN
-
urn:nbn:de:101:1-2020051016195341573807
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhao, Deze
- Jiang, Man
- Zhang, Xiaochun
- Hou, Helei
- SpringerLink (Online service)
Other Objects (12)
Noncoding RNAs in cancer therapy resistance and targeted drug development
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
Consensus on targeted drug therapy for spondyloarthritis
Computational drug design based in natural leads to overcome drug resistance in targeted and pan-cancer therapy
Estimating tuberculosis drug resistance amplification rates in high-burden settings
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
Peptide-drug conjugates for advanced targeted cancer therapy
Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy
The role of SOX2 in resistance towards targeted therapy
The role of SOX2 in resistance towards targeted therapy
Partial reprogramming - a model for melanoma targeted therapy resistance
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
Noncoding RNAs in cancer therapy resistance and targeted drug development
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
Consensus on targeted drug therapy for spondyloarthritis
Computational drug design based in natural leads to overcome drug resistance in targeted and pan-cancer therapy
Estimating tuberculosis drug resistance amplification rates in high-burden settings
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
Peptide-drug conjugates for advanced targeted cancer therapy
Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy
The role of SOX2 in resistance towards targeted therapy
The role of SOX2 in resistance towards targeted therapy
Partial reprogramming - a model for melanoma targeted therapy resistance
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
Noncoding RNAs in cancer therapy resistance and targeted drug development
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
Consensus on targeted drug therapy for spondyloarthritis
Computational drug design based in natural leads to overcome drug resistance in targeted and pan-cancer therapy
Estimating tuberculosis drug resistance amplification rates in high-burden settings
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
Peptide-drug conjugates for advanced targeted cancer therapy
Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy
The role of SOX2 in resistance towards targeted therapy
The role of SOX2 in resistance towards targeted therapy
Partial reprogramming - a model for melanoma targeted therapy resistance